Literature DB >> 10614153

[Everyday memory impairment in Parkinson's disease].

S Katai1.   

Abstract

Memory impairment has been frequently reported in patients with Parkinson's disease. The traditional tests used in previous studies, however, failed to sufficiently reflect memory performance in everyday life. To investigate everyday memory in patients with Parkinson's disease, an objective test of everyday memory, the Rivermead Behavioural Memory Test (RBMT), and an everyday memory questionnaire were administered to 26 parkinsonian patients and 26 age-matched normal controls. The parkinsonian patients scored significantly lower on the RBMT than the controls (p < 0.01). Moreover, the parkinsonian patients performed especially poorly on subtests related to prospective memory (p < 0.05). These subtests are thought to be sensitive to frontal lobe function. On the everyday memory questionnaire, the parkinsonian patients estimated their own everyday memory to be significantly worse than did the controls (p < 0.01). Further, the patients estimated their everyday memory to be especially poor in comparison with the controls on the sub-items related to recency memory (p < 0.05), source memory (p < 0.01), action slip (p < 0.01), and tip-of-the-tongue phenomenon (p < 0.05). In the patient group, the RBMT score correlated significantly with the scores on the Wisconsin Card Sorting Test (p < 0.05) and tests of verbal fluency (p < 0.05). These results indicate that everyday memory is impaired in patients with Parkinson's disease, and that this impairment is partly related to frontal lobe dysfunction.

Entities:  

Mesh:

Year:  1999        PMID: 10614153

Source DB:  PubMed          Journal:  Rinsho Shinkeigaku        ISSN: 0009-918X


  1 in total

1.  A differential deficit in time- versus event-based prospective memory in Parkinson's disease.

Authors:  Sarah A Raskin; Steven Paul Woods; Amelia J Poquette; April B McTaggart; Jim Sethna; Rebecca C Williams; Alexander I Tröster
Journal:  Neuropsychology       Date:  2011-03       Impact factor: 3.295

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.